Sign Up
Stories
Pharma Market Booms with Acquisitions
Share
AB Science's Medical Breakthrough Webcas...
ABBio Innovates Antibody Development
ABIONYX Pharma Files 2023 Document
AscellaHealth Forecasts Robust Outlook f...
Big Pharma Faces Revenue Loss from Paten...
Biologics Market Insights
Overview
API
The global API market is set to hit USD 352.98 billion by 2030, propelled by biopharmaceutical growth, manufacturing advancements, and aging demographics. Developing nations like India are becoming favored for API production. Merck & Co Inc. recently acquired Acceleron Pharma to bolster their cardiovascular offerings.
Ask a question
How might the acquisition of Acceleron Pharma impact Merck & Co Inc.'s market position?
How will advancements in API manufacturing shape the future of pharmaceutical production?
What challenges and opportunities could arise for developing nations entering the API market?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Jan 2024
Feb 2024
Mar 2024
Coverage